Cellnovo Group (“Cellnovo” CLNV: EN Paris), a medical technology company marketing the first mobile, connected, all-in-one diabetes management system, today announces that its manufacturing partner, Flex (Flex.com), the Sketch-to-Scale™ solutions provider that designs and builds Intelligent Products for a Connected World™, has completed the first commercial batch of consumables for its diabetes management system. This development comes at the end of a period of extensive testing and validation of the mass produced Cellnovo system insulin cartridges to ensure the optimal functionality of the new mass production line at Flex’s facility in Althofen, Austria, which is expected to be operating at full capacity this summer.